Meeting NewsVideo

VIDEO: New brand of loteprednol has increased penetration

NEW YORK – Marc Bloomenstein, OD, said he uses Kala’s new Inveltys (loteprednol etabonate ophthalmic suspension 1%) in both cataract and refractive surgery patients.

It is an “amplified version of loteprednol that makes the molecules much smaller and allows them to traverse through the mucin of the tears and penetrate into the anterior chamber at a significantly higher concentration,” he said. “At a cataract and refractive surgery center, one thing we’re always looking for is something with a low incidence of causing sequalae but a high potential of penetration into the eye, especially with a steroid.”

NEW YORK – Marc Bloomenstein, OD, said he uses Kala’s new Inveltys (loteprednol etabonate ophthalmic suspension 1%) in both cataract and refractive surgery patients.

It is an “amplified version of loteprednol that makes the molecules much smaller and allows them to traverse through the mucin of the tears and penetrate into the anterior chamber at a significantly higher concentration,” he said. “At a cataract and refractive surgery center, one thing we’re always looking for is something with a low incidence of causing sequalae but a high potential of penetration into the eye, especially with a steroid.”

    See more from Vision Expo East